Rapid Point-of-Care Diagnostic Device for COVID-19
COVID-19 快速护理点诊断设备
基本信息
- 批准号:54731
- 负责人:
- 金额:$ 13.94万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Feasibility Studies
- 财政年份:2020
- 资助国家:英国
- 起止时间:2020 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
GB Electronics (UK) ltd., (GBE), a design-led manufacturing UK based SME is working with Brunel University London (BUL) to help them bring to market their low-cost and portable smart molecular diagnostic platform for the detection of SARS-CoV-2 (Covid-19).Prior to the Coronavirus Pandemic, an early stage version of the product was being developed by a research team led by BUL in collaboration with the University of Lancaster and the University of Surrey and intended to be used for detecting viral pathogens in poultry, funded by the Biotechnology and Biological Science Research Council (BBSRC). The research team established that with some modification their product could use a Loop Mediated Isothermal Amplification (LAMP) assay to detect COVID-19 directly from a patient sample (nasal or throat swabs) within 30 minutes. Another strength of their design was that it analysed six samples per cycle and was being specifically developed for low-cost deployment in the developing world.A set of eight early stage products are currently undergoing laboratory and clinical validation studies at NHS Laboratories. The results of which will be used to further optimise the diagnostic algorithm and the physical design of the product.GBE will then assist with the manufacture of a batch of beta products, which will be a design iteration based on the initial trial units. This increases the amount of clinical trial data available and will provide essential feedback on the functionality of the product.The beta units will then undergo a significant 'cost-down' design for manufacture stage in order to prepare for mass production. This stage will involve refinement of the hardware, firmware and mechanical design plus development of a robust communications protocol. It will be manufactured in-house at GBE's Sussex based factory.All work will be carried out in conjunction with Brunel and their team in order to optimise the efficacy of the product. Whilst gathering additional functional data we will also prepare detailed market analysis to maximise the global and industrial potential of the product. With a keen focus on the needs of the developing world, where product cost is vital.GBE has over 30 years' experience of embedded product development and manufacturing. This includes a very successful track record within the healthcare market plus experience of working with innovative product launches and solutions.Development of the product, now called the Virus Hunter 6 ( VH-6), has been at an accelerated pace. This has been along with the exponentially growing public need for a rapid point-of-care Covid-19 diagnostic device. We had the opportunity to accelerate development and allocate resources to this project, however this had meant the grant was quickly used and GBE has also funded additional work over the last 6 months. This was also in part due to the cutting edge aspects of this project, plus the constantly changing requirements: this Pandemic has seen the world enter very challenging times and all efforts are focused on dealing with this ‘new normal’. The design path has had to be extremely flexible as both the science (of the virus and its propagation) evolve along with the national and international response to it are changing on an almost weekly basis. Four key new deliverables have been identified which will have a significant impact in the rapid development and deployment of this Covid-19 detector. These are to be carried out over the next three months and will also include a real-life controlled trial of 1,500 tests at University of Surrey (for current students and employees) vs a gold standard PCR. Success will lead to expanding this to all of Surrey and Brunel University London (over 30,000 students and employees). Data gathered will be instrumental to rapid deployment of the product - enhancing its functionality and providing additional data for new scientific publications. Alongside this, we have an opportunity for smaller real-life controlled trials.
GB Electronics (UK) ltd. (GBE)是一家以设计为主导的英国制造中小企业,目前正与伦敦布鲁内尔大学(BUL)合作,帮助他们将低成本、便携式的智能分子诊断平台推向市场,用于检测SARS-CoV-2 (Covid-19)。在冠状病毒大流行之前,由喀布尔大学领导的一个研究小组正在与兰开斯特大学和萨里大学合作开发该产品的早期版本,旨在用于检测家禽中的病毒病原体,由生物技术和生物科学研究委员会(BBSRC)资助。研究小组确定,经过一些修改,他们的产品可以使用环介导等温扩增(LAMP)法在30分钟内直接从患者样本(鼻或咽拭子)中检测出COVID-19。他们设计的另一个优势是,它每周期分析6个样本,并且是专门为发展中国家的低成本部署而开发的。一组8个早期阶段的产品目前正在NHS实验室进行实验室和临床验证研究。其结果将用于进一步优化诊断算法和产品的物理设计。然后,GBE将协助制造一批测试产品,这将是基于初始试验单元的设计迭代。这增加了可用的临床试验数据量,并将提供有关产品功能的基本反馈。然后,测试单元将经历一个重要的“降低成本”的制造设计阶段,以便为大规模生产做准备。这一阶段将涉及硬件、固件和机械设计的细化以及健壮通信协议的开发。它将在GBE位于苏塞克斯的工厂内部制造。所有工作都将与Brunel和他们的团队一起进行,以优化产品的功效。在收集其他功能数据的同时,我们还将准备详细的市场分析,以最大限度地发挥产品的全球和工业潜力。对产品成本至关重要的发展中国家的需求有着敏锐的关注。GBE拥有超过30年的嵌入式产品开发和制造经验。这包括在医疗保健市场中非常成功的记录,以及与创新产品发布和解决方案合作的经验。该产品现在被称为病毒猎手6 (VH-6),其开发速度一直在加快。与此同时,公众对Covid-19即时诊断设备的需求呈指数级增长。我们本有机会加速开发并为该项目分配资源,但这意味着赠款很快就被使用了,GBE还在过去6个月里资助了额外的工作。这在一定程度上也是由于这个项目的尖端方面,加上不断变化的需求:这次大流行使世界进入了非常具有挑战性的时期,所有的努力都集中在应对这一“新常态”上。设计路径必须非常灵活,因为(关于病毒及其传播的)科学随着国家和国际应对措施的变化而不断发展,几乎每周都在变化。已经确定了四项关键的新成果,这将对快速开发和部署这种Covid-19检测器产生重大影响。这些将在接下来的三个月里进行,还将包括在萨里大学(针对在校生和员工)进行的1500项现实对照试验,与金标准PCR相比。成功将导致扩展到整个萨里和布鲁内尔大学伦敦(超过30,000名学生和员工)。收集的数据将有助于产品的快速部署——增强其功能并为新的科学出版物提供额外的数据。除此之外,我们还有机会进行小规模的现实对照试验。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
其他文献
吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('', 18)}}的其他基金
An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
- 批准号:
2901954 - 财政年份:2028
- 资助金额:
$ 13.94万 - 项目类别:
Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
- 批准号:
2896097 - 财政年份:2027
- 资助金额:
$ 13.94万 - 项目类别:
Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
- 批准号:
2780268 - 财政年份:2027
- 资助金额:
$ 13.94万 - 项目类别:
Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
- 批准号:
2908918 - 财政年份:2027
- 资助金额:
$ 13.94万 - 项目类别:
Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
- 批准号:
2908693 - 财政年份:2027
- 资助金额:
$ 13.94万 - 项目类别:
Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
- 批准号:
2908917 - 财政年份:2027
- 资助金额:
$ 13.94万 - 项目类别:
Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
- 批准号:
2879438 - 财政年份:2027
- 资助金额:
$ 13.94万 - 项目类别:
Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
- 批准号:
2890513 - 财政年份:2027
- 资助金额:
$ 13.94万 - 项目类别:
Studentship
CDT year 1 so TBC in Oct 2024
CDT 第 1 年,预计 2024 年 10 月
- 批准号:
2879865 - 财政年份:2027
- 资助金额:
$ 13.94万 - 项目类别:
Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
- 批准号:
2876993 - 财政年份:2027
- 资助金额:
$ 13.94万 - 项目类别:
Studentship
相似国自然基金
解大型非对称鞍点(Saddle Point) 问题的有效算法的研究
- 批准号:60573157
- 批准年份:2005
- 资助金额:20.0 万元
- 项目类别:面上项目
相似海外基金
ICF: Development of a rapid diagnostic test to identify Crimean-Congo Haemorrhagic Fever at the point-of-care
ICF:开发快速诊断测试以在护理点识别克里米亚-刚果出血热
- 批准号:
MR/Y019431/1 - 财政年份:2024
- 资助金额:
$ 13.94万 - 项目类别:
Research Grant
AMBROSIA: A Multiplexed Plasmo-Photonic Biosensing Platform For Rapid And Intelligent Sepsis Diagnosis At The Point- Of-Care
AMBROSIA:用于护理点快速智能脓毒症诊断的多重等离子体光子生物传感平台
- 批准号:
10066297 - 财政年份:2023
- 资助金额:
$ 13.94万 - 项目类别:
EU-Funded
Test, treat, and connect on site using a dual rapid diagnostic point-of-care test for syphilis and HIV among people who are experiencing houselessness
使用梅毒和艾滋病毒双重快速诊断现场检测对无家可归者进行现场检测、治疗和联系
- 批准号:
489125 - 财政年份:2023
- 资助金额:
$ 13.94万 - 项目类别:
Operating Grants
Innovative Rapid Enabling, Affordable, point-of-Care HPV Self-Testing Strategy (I-REACH)
创新的快速、经济、即时护理 HPV 自检策略 (I-REACH)
- 批准号:
10648634 - 财政年份:2023
- 资助金额:
$ 13.94万 - 项目类别:
Rapid Point of Care Test to Screen Human Papillomavirus in Low-Resource Settings
在资源匮乏的环境中筛查人乳头瘤病毒的快速护理点测试
- 批准号:
10897682 - 财政年份:2023
- 资助金额:
$ 13.94万 - 项目类别:
SBIR Phase II: Integrated Point-of-Care System for Rapid Pathogen Identification and Characterization
SBIR 第二阶段:用于快速病原体识别和表征的集成护理点系统
- 批准号:
2321834 - 财政年份:2023
- 资助金额:
$ 13.94万 - 项目类别:
Cooperative Agreement
REACHing underserved and undiagnosed populations living with STBBIs to test and link them to care: Implementing innovative clinical trials (iCTs) designs to "test and treat" and bring new rapid point-of-care and self-tests to market in Canada
覆盖服务不足和未确诊的 STBBI 患者,对他们进行测试并将其与护理联系起来:实施创新的临床试验 (iCT) 设计来“测试和治疗”,并将新的快速护理点和自我测试推向加拿大市场
- 批准号:
481601 - 财政年份:2023
- 资助金额:
$ 13.94万 - 项目类别:
Operating Grants
SBIR Phase II: Point-of-Care Electrochemical Platform for the Rapid Detection of Drug Toxicity
SBIR II 期:用于快速检测药物毒性的即时电化学平台
- 批准号:
2309437 - 财政年份:2023
- 资助金额:
$ 13.94万 - 项目类别:
Cooperative Agreement
Rapid, simple, and ultrasensitive quantitation of KRAS ctDNA at the point of care using CRISPR/Cas amplification and digital resolution biosensor microscopy
使用 CRISPR/Cas 扩增和数字分辨率生物传感器显微镜在护理点快速、简单且超灵敏地定量 KRAS ctDNA
- 批准号:
10709211 - 财政年份:2023
- 资助金额:
$ 13.94万 - 项目类别:
SBIR PA22-176 - Rapid Point-of-Care Detection of Human Papillomavirus
SBIR PA22-176 - 人乳头瘤病毒的快速护理点检测
- 批准号:
10761537 - 财政年份:2023
- 资助金额:
$ 13.94万 - 项目类别: